Weight Variation During Chemotherapy in Breast Cancer Patients

Centre Jean Perrin

Status: Completed

Conditions: Breast Cancer

Treatments: Other: blood test/ additional measurement

Study type: Interventional

Funder types: Other

Identifiers

NCT01506466

2011-A00206-35

Details and patient eligibility

About

Weight variation has been reported as a side effect of chemotherapy treatment in early breast cancer patients. To date, there is growing evidence for an increased risk of relapse and death in these patients who gain or lose weight. However, causes of weight variation during chemotherapy and mechanisms involved in the poor prognosis have been little studied.

Thus, the investigators are conducting a prospective study to characterize weight variation in terms of body composition and to identify the mechanisms involved.

Enrollment: 52 patients

Sex: Female

Ages: Under 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• menopausal women
• breast cancer
• patients requiring chemotherapy treatment
• WHO performance status 0-2

Exclusion criteria

• diabetics
• patients with metastases
• other cancer

Trial design

52 participants in 1 patient group

additional examinations/measurements

Other group

Treatment:

Other: blood test/ additional measurement